Alabama Vaccine CRS

Birmingham, Alabama 35294-2041

0 studies enrolling now · 19 studies all time

What they study most

COVID-19, HIV Infections, HIV Seronegativity, SARS-CoV-2

Studies at this site

• Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19 — Completed
• Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults — Completed
• An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials — Completed
• HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult Participants — Completed
• Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B — Completed
• Early Immune Responses to Vaccination - A Substudy to HVTN 205 — Completed
• A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines — Completed
• Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults — Completed
• Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults — Completed
• An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV — Completed
• Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults — Completed
• Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults — Completed
• Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults — Completed
• Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults — Completed
• Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults — Completed
• Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults — Completed
• Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults — Completed
• Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults — Completed
• Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP — Completed